Synthesis, incorporation into triplex-forming oligonucleotide, and binding properties of a novel 2′-deoxy-C-nucleoside featuring a 6-(Thiazolyl-5)benzimidazole nucleobase

Organic Letters

Volumn 4, Issue 24, 2002, Pages 4209-4212

  Guianvarc'h, Dominique ^a   Fourrey, Jean Louis ^a   Maurisse, Rosalie ^b   Sun, Jian Sheng ^b   Benhida, Rachid ^a,c  

^a CNRS   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 (THIAZOLYL 5)BENZIMIDAZOLE; 6-(THIAZOLYL-5)BENZIMIDAZOLE; ADENINE; BENZIMIDAZOLE DERIVATIVE; DNA; NUCLEOSIDE; OLIGONUCLEOTIDE; THYMINE; TRIPLEX DNA;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DNA DENATURATION; HYDROGEN BOND; NUCLEOTIDE SEQUENCE; SYNTHESIS; TEMPERATURE;

ADENINE; BASE SEQUENCE; BENZIMIDAZOLES; DNA; HYDROGEN BONDING; MOLECULAR STRUCTURE; NUCLEIC ACID DENATURATION; NUCLEOSIDES; OLIGONUCLEOTIDES; TEMPERATURE; THYMINE;

EID: 0037191631     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol026609h     Document Type: Article

References (41)

1. The symbols ·and x indicate Watson-Crick and Hoogsteen hydrogen bonds, respectively.
2. (a) Le Doan, T.; Perrouault, L.; Praseuth, D.; Habhoub, N.; Decout, J. L.; Thuong, N. T.; Lhomme, J.; Hélène, C. Nucleic Acids Res. 1987, 15, 7749-7760.
3. (b) Moser, H. E.; Dervan, P. B. Science 1987, 238, 645-650. For reviews, see:
4. (c) Thuong, N. T.; Hélène, C. Angew. Chem., Int. Ed. Engl. 1993, 32, 666-690.
5. (d) Frank-Kamenetskii, M. D.; Mirkin, S. M. Annu. Rev. Biochem. 1995, 64, 65-95.
6. (e) Neidle, S. Anti-Cancer Drug Des. 1997, 12, 433-442.
7. (a) Maher, J. L., III. Cancer Invest. 1996, 14, 66-82.
8. (b) Giovannangeli, C.; Hélène, C. Antisense Nucleic Acid Drug Dev. 1997, 7, 413-421.
9. (c) Vasquez, K. M.; Wilson, J. H. Trends Biochem. Sci. 1998, 23, 4-9.
10. (d) Praseuth, D. Guieysse-Peugeot, A. L.; Hélène, C. Biochim. Biophys. Acta 1999, 1489, 181-206.
11. (a) Mergny, J. L.; Sun, J. S.; Rougée, M.; Garestier, T.; Barcelo, F.; Chomilier, J.; Hélène, C. Biochemistry 1991, 30, 9791-9798.
12. (b) Greenberg, W. A.; Dervan, P. B. J. Am. Chem. Soc. 1995, 117, 5016-5022.
13. (c) Best, G. C.; Dervan, P. B. J. Am. Chem. Soc. 1995, 117, 1187-1193.
14. Reviews: (a) Sun, J. S.; Hélène, C. Curr. Opin. Struct. Biol. 1993, 3, 145-356.
15. (b) Doronina, S. O.; Behr, J. P. Chem. Soc. Rev. 1997, 26, 63-71.
16. (c) Gowers, D. M.; Fox, K. R. Nucleic Acids Res. 1999, 27, 1569-1577 and references therein.
17. (a) Griffin, L. C.; Kiessling, L. L.; Beal, P. A.; Gillespie, P.; Dervan, P. B. J. Am. Chem. Soc. 1992, 114, 7976-7982.
18. (b) Koshlap, K. M.; Gillespie, P.; Dervan, P. B.; Feigon, J. J. Am. Chem. Soc. 1993, 115, 7908-7909.
19. (c) Huang, C. Y.; Cushman, C. D.; Miller, P. S. J. Org. Chem. 1993, 58, 5048-5049.
20. (d) Huang, C. Y.; Miller, P. S. J. Am. Chem. Soc. 1993, 15, 10456-10457.
21. (e) Huang, C. Y.; Bi, G.; Miller, P. S. Nucleic Acids Res. 1996, 24, 2606-2613.
22. (f) Lehmann, T. E.; Greenberg, W. A.; Liberles, D. A.; Wada, C. K.; Dervan, P. B. Helv. Chim. Acta 1997, 80, 2002-2022.
23. (g) Obika, S.; Hari, Y.; Sekiguchi, M.; Imanishi, T. Angew. Chem., Int. Ed. 2001, 40, 2079-2081.
24. Guianvarc'h, D.; Benhida, R.; Fourrey, J.-L.; Maurisse, R.; Sun, J. S. J. Chem. Soc., Chem. Commun. 2001, 1814-1815.
25. For reviews on the chemistry, biochemistry, and synthesis of C-nucleosides analogues, see: (a) Buchanan, J. G. Prog. Chem. Org. Nat. Prod. 1983, 44, 243-299.
26. (b) Hacksell, U.; Daves, G. D., Jr. Prog. Med. Chem. 1985, 22, 1-65.
27. (c) Postema, M. H. D. Tetrahedron 1992, 40, 8545-8599.
28. (d) Watanabe, K. A. Chemistry of Nucleosides and Nucleotides; Townsend, L. B., Ed.; Plenum Press: New York, 1994; Vol. 3, pp 421-535.
29. (e) Jaramillo, C.; Knapp, S. Synthesis 1994, 1-20.
30. (f) Chaudhuri, N. C.; Ren, R. X. F.; Kool, E. T. Synlett 1997, 341-347.
31. (g) Togo, H.; He, W.; Waki, Y.; Yokoyama, M. Synlett 1998, 700-716.
32. Benhida, R.; Lecubin, F.; Fourrey, J.-L.; Rivas, L.; Quintero, L. Tetrahedron Lett. 1999, 40, 5701-5703.
33. (a) Stille, J. K. J. Am. Chem. Soc. 1979, 4992-4998.
34. (b) Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 25, 508-524.
35. 13C NMR spectra, we only used the 6-isomer in the next steps of our synthesis.
36. Lee, J. G.; Cha, H. T. Tetrahedron Lett. 1992, 33, 3167-3168.
37. We have verified that this lithiation occurred exclusively and quantitatively at the C-2 position of the benzimidazole moiety by trapping the lithio derivatives with hexachloroethane.
38. Joos, P. E.; Esmans, E. L.; Domisse, R. A.; De Bruyn, A.; Balzarini, J. M.; De Clercq, E. D. Helv. Chim. Acta 1992, 75, 1613-1620.
39. The R and S configurations of compounds 8 and 9 were determined on the basis of the anomeric stereochemistry of their cyclized products 12 and 13, respectively (NOESY experiments).
40. 2-type mechanism for the outcome of this reaction.
41. In the same way, we observed for the other anomers (12(α) and 13(α) obtained from 10R and 11R, respectively) clear NOE H1′-H3′ and H1′-H5′ correlations, in accordance with an α configuration.